Investigating GSTP1 as a novel regulator of the cysteine redoxome in breast cancer and maker of vulnerability to redox-based therapy
Investigating GSTP1 as a novel regulator of the cysteine redoxome in breast cancer and maker of vulnerability to redox-based therapy
批准号:
10576645
负责人:
Jason M. Held
金额:
$18.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-12-12 至 2024-11-30
关键词:
AffectAntioxidantsBiologicalBiological AssayBiological MarkersBiologyBreast Cancer CellBreast Cancer cell lineCancer PatientCancer cell lineCell LineCellsCessation of lifeChemistryClinicClinicalClinical TrialsComplementComplexCysteineDiseaseElectronsEndocrineEnzymesEvaluationGlutathioneGrowthIn VitroMalignant NeoplasmsMalignant neoplasm of liverMalignant neoplasm of prostateMetabolicModalityModelingMolecularNADPH OxidaseNeoplasm MetastasisOncogenicOrganoidsOxidation-ReductionPathway interactionsPatientsPhenotypeProteinsProteomeRegulationRelapseReportingRepressionResistanceRoleSentinelSignal TransductionSignaling ProteinTechniquesTestingTherapeuticTreatment EfficacyUp-Regulationacetovanilloneacquired treatment resistanceanti-cancercancer subtypescancer typecandidate identificationcandidate markercysteinesulfenic aciddisulfide bondebselenepigenetic regulationepigenetic silencingglutathione S-transferase piin vivoinhibitorinsightinterestmRNA Expressionmalignant breast neoplasmmolecular markernovelnovel markeroverexpressionoxidationpatient derived xenograft modelpharmacodynamic biomarkerpredictive markerprognosticprotein expressionprotein functionprotein protein interactionprotein structuresensorsmall moleculetranscriptomicstumortumorigenesis
中文摘要
项目摘要
谷胱甘肽S-转移酶Pi 1(GSTP 1)是一种将谷胱甘肽结合到小分子
亲电分子GSTP 1与促进许多癌症的生长有关
GSTP 1过表达促进代谢重新连接或隔离的类型
通过蛋白质-蛋白质相互作用的癌症相关信号蛋白。
与这些研究报道的癌症中GST 1的适度上调相反,我们的研究发现,
对癌细胞系、患者来源的异种移植物和患者肿瘤的系统评价发现,
GSTP 1的表达在管腔内被独特地和显著地沉默了许多数量级。
乳腺癌,从最丰富的细胞蛋白之一到几乎不表达。Her2
阳性(Her 2+)乳腺癌具有双峰GSTP 1表达分布,
比例也沉默GSTP 1。
乳腺癌中GSTP 1表达的降低使我们发现了一种新的、非经典的
GSTP 1的调节功能:重新定向半胱氨酸氧化的通量,以在结构上重塑
蛋白质组通过变构二硫键。这些变化对乳腺癌至关重要
由于GST 1的再表达和氧化还原信号传导的抑制降低了转化,
GSTP 1沉默的乳腺癌细胞的转化能力。
这项建议集中于两个具体目标。首先,GSTP 1沉默是一种治疗方法吗?
BRCA的弱点?第二,什么是GST 1的分子和氧化还原体的后果
沉默总之,这些目标将提供新的机制洞察如何GST 1表达
驱动乳腺癌中的氧化还原信号传导,并确定GSTP 1沉默是否是治疗性的
可采取行动的脆弱性。
英文摘要
Project Summary
Glutathione S-transferase Pi 1 (GSTP1) is an enzyme that conjugates glutathione to small
molecule electrophiles. GSTP1 has been implicated in promoting the growth of many cancer
types where GSTP1 overexpression is proposed to promote metabolic re-wiring or sequester
cancer-related signaling proteins through protein-protein interactions.
In contrast to the modest upregulation of GSTP1 in cancer reported by these studies, our
systematic evaluation of cancer cell lines, patient-derived xenografts, and patient tumors finds that
GSTP1 expression is uniquely and dramatically silenced by many orders of magnitude in luminal
breast cancer, going from one of the most abundant cellular proteins to barely express. Her2
positive (Her2+) breast cancers have a bimodal GSTP1 expression distribution, with a significant
proportion also silencing GSTP1.
Decreased GSTP1 expression in breast cancer allowed us to discover a novel, non-canonical
regulatory function of GSTP1: re-directing the flux of cysteine oxidation to structurally remodel the
proteome via allosteric disulfide bonds. These changes are critical for breast cancer
transformation since re-expression of GSTP1 and inhibition of redox signaling decreases the
transformation capacity of GSTP1-silenced breast cancer cells.
This proposal focuses on two Specific Aims. First, is GSTP1 silencing a therapeutic
vulnerability in BRCA? Second, what are the molecular and redoxomic consequences of GSTP1
silencing? Together, these Aims will provide new mechanistic insight into how GSTP1 expression
drives redox signaling in breast cancer and determine if GSTP1 silencing is a therapeutically
actionable vulnerability.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using Optogenetics to Dissect the Role of Redox Signaling During C. Elegans Aging
-
批准号:9751694
-
项目类别:
-
资助金额:$19.61万
-
财政年份:2018
-
负责人:Jason M. Held
-
依托单位:
INVESTIGATING NAPDH OXIDASES AND REDOX SIGNALING IN LUNG CANCER TUMORIGENICITY
-
批准号:9283379
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2016
-
负责人:Jason M. Held
-
依托单位:
INVESTIGATING NAPDH OXIDASES AND REDOX SIGNALING IN LUNG CANCER TUMORIGENICITY
-
批准号:9175407
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2016
-
负责人:Jason M. Held
-
依托单位:
The role of p53 redox-modification in cell fate signaling
-
批准号:8569469
-
项目类别:
-
资助金额:$20.48万
-
财政年份:2013
-
负责人:Jason M. Held
-
依托单位:
The role of p53 redox-modification in cell fate signaling
-
批准号:8680191
-
项目类别:
-
资助金额:$16.84万
-
财政年份:2013
-
负责人:Jason M. Held
-
依托单位:
OxMRM: A Technique to Quantify Oxidation of Endogenous Redox-Sensitive Cysteines
-
批准号:8035283
-
项目类别:
-
资助金额:$28.98万
-
财政年份:2009
-
负责人:Jason M. Held
-
依托单位:
OxMRM: A Technique to Quantify Oxidation of Endogenous Redox-Sensitive Cysteines
-
批准号:7798156
-
项目类别:
-
资助金额:$29.88万
-
财政年份:2009
-
负责人:Jason M. Held
-
依托单位:
OxMRM: A Technique to Quantify Oxidation of Endogenous Redox-Sensitive Cysteines
-
批准号:7628935
-
项目类别:
-
资助金额:$25.61万
-
财政年份:2009
-
负责人:Jason M. Held
-
依托单位:
海外基金